Buy & Sell Ascendis Pharma A/S (ASND) – Ascendis Pharma A/S Price Today
Aura AI Summary
Key Stats
- $13.92BMarket Cap
- HealthSector
- -10.97%3M Drawdown
- $14.21BEnterprise Value
- -Dividend Yield
- 48 daysTypical Hold Time
Ascendis Pharma A/S (ASND) is currently valued at a market capitalization of $13.92B, with an enterprise value of $14.21B. Over the past 52 weeks, Ascendis Pharma A/S has traded between a low of $137.41 and a high of $242.09, highlighting its annual price range. Over the past three months, Ascendis Pharma A/S has recorded a drawdown of -10.97%, reflecting recent price volatility. Ascendis Pharma A/S offers a dividend yield of -. On average, investors hold Ascendis Pharma A/S for approximately 48 days, indicating typical investor behavior on the platform.
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
